Relations Between Atherogenic Index of Plasma-Glucose Metabolism

NCT02977598 | Completed

• 1 other identifier: 44495147/1-202
• Study Type: observational
• Target: 448
• Locations: 1 country
• Sites: 2

Brief Summary

In this study, the investigators aimed to find out whether there is any association between the atherogenic index of plasma with the glucose metabolism.In this respect, apart from the well-known diabetic risk factors, the investigators purposed to reveal new ones.

Conditions

Diabetes Mellitus Risk

Outcome Measures

Primary Outcomes (1)

• Atherogenic index of plasma (AIP) values compared with glucose metabolism parameters like HbA1c, Fasting Plasma Glucose and 2-hour plasma glucose levels.

  6 months

Study Arms (3)

non-diabetic

According to the 75 g oral glucose tolerance test participants were categorized into the three groups; non-diabetic, prediabetic, and diabetic based on the criteria of the American Diabetes Association.

prediabetic

According to the 75 g oral glucose tolerance test participants were categorized into the three groups; non-diabetic, prediabetic, and diabetic based on the criteria of the American Diabetes Association.

diabetic

According to the 75 g oral glucose tolerance test participants were categorized into the three groups; non-diabetic, prediabetic, and diabetic based on the criteria of the American Diabetes Association.

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

448 healthy individuals who were at risk for diabetes. According to the 75 g oral glucose tolerance test participants were categorized into the three groups; non-diabetic, prediabetic, and diabetic based on the criteria of the American Diabetes Association.

You may qualify if:

• All the participants were previously healthy, aged between 18 and 80 years, and were at risk for diabetes according to new criteria provided by the American Diabetes Association.

You may not qualify if:

• Individuals with a history of chronic medical diseases and those who reported current use of any medication were excluded from the study

Sponsors & Collaborators

• Erzincan University: lead

Study Sites (2)

Erzincan Mengucekgazi Research and Training Hospital

Erzincan, 00024, Turkey (Türkiye)

Location

Erzincan Mengücekgazi Training and Research Hospital

Erzincan, 00024, Turkey (Türkiye)

Location

Study Officials

• EMIN MURAT AKBAS, Assoc. Prof.

  ERZINCAN MENGUCEKGAZI TRAINING AND RESEARCH HOSPİTAL DEPARTMENT OF ENDOCRINOLOGY AND METABOLIC DISEASES

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Internal medicine, medical doctor

Study Record Dates

• First Submitted: November 20, 2016
• First Posted: November 30, 2016
• Study Start: February 1, 2014
• Primary Completion: December 1, 2014
• Study Completion: February 1, 2015
• Last Updated: November 30, 2016

Record last verified: 2016-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (2)